Area of research
Pulmonary and Respiratory Medicine · Statistics and Probability
Research interest
Research interests include Medicine, Ivacaftor, Cystic fibrosis, Tolerability, Internal medicine, and Confidence interval.
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials
Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One <i>F508del</i> Allele